Yılmaz A. Commentary on the Prognostic Interpretation of the Triglyceride-Glucose Index in Patients with HCM and HFpEF. Anatol J Cardiol. 2026 ;30(3):204-205. doi: 10.14744/AnatolJCardiol.2025.6029.
Yılmaz A. Commentary on the Prognostic Interpretation of the Triglyceride-Glucose Index in Patients with HCM and HFpEF. Anatol J Cardiol. 2026;30(3):204-205. doi: 10.14744/AnatolJCardiol.2025.6029
Yılmaz, A. (2026). Commentary on the Prognostic Interpretation of the Triglyceride-Glucose Index in Patients with HCM and HFpEF. The Anatolian Journal of Cardiology, 30(3), 204-205. https://doi.org/10.14744/AnatolJCardiol.2025.6029
Yılmaz, A.. "Commentary on the Prognostic Interpretation of the Triglyceride-Glucose Index in Patients with HCM and HFpEF." The Anatolian Journal of Cardiology, vol. 30, no. 3, 2026, pp. 204-205. https://doi.org/10.14744/AnatolJCardiol.2025.6029.
Yılmaz, A.. 2026. "Commentary on the Prognostic Interpretation of the Triglyceride-Glucose Index in Patients with HCM and HFpEF." The Anatolian Journal of Cardiology 30, no. 3: 204-205. https://doi.org/10.14744/AnatolJCardiol.2025.6029.
